A manual ELISA-based diagnostic test for the tumor marker TPS (Tissue Polypeptide-Specific Antigen). This product is part of IDL Biotech's tumor marker product line that has been licensed to Beckman Coulter Diagnostics for global distribution.
Manufactured by
Bromma, Sweden
IDL Diagnostics is a Swedish diagnostics company with the vision to improve the monitoring of oncological and bacterial diseases. We have a broad product portfolio of IVD tests that deliver high-value clinical information for the detection of disease with indications spanning everything from urological cancers to typhoid fever. IDL Diagnostics targets different patient groups in different parts of the world. With an organization that occupies the entire value chain from R D to manufacturing and marketing, we have the flexibility of a small company and the characteristics of a big company. It enables us to be a fast mover in the fast growing field of IVD-tests This is critical for us to be able deliver on our vision to be valuable and relevant diagnostic partner in oncology healthcare. Based on our proprietary technologies and our biomarkers, we develop tests that are clinically useful and economically viable, making us a valuable and relevant diagnostic partner for healthcare professionals. We provide rapid tests, laboratory tests and platform tests that improve decision making and are non-invasive, cost effective, and easy to perform – all of which are important criteria for the healthcare and payer community. At IDL Diagnostics, we are proud that our diagnostic solutions can contribute to one of the three imperatives for reducing the burden of disease: diagnostics, therapeutics and vaccines. In the wake of covid-19, it is fair to say that diagnostics has been given a well-deserved place in the healthcare limelight. With a growing number of elderly people around the world in combination with an increase in the incidence of chronic diseases, the need for accurate diagnostics is essential. We create value for our shareholders by executing our strategy of increasing sales volumes in existing markets, obtaining market approvals in other prioritized markets, and continuously developing the next generation of IVD tests. With a pipeline that meets current and future demands, we stay relevant not only to patients, but to all our stakeholders. IDL Diagnostics was first listed in 2016 and our shares are traded on Stockholm Nasdaq First North.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Beijing Hotgen Biotech Co.,Ltd
China · 3 relevant products
Vitrotest Bioreagent LLC
Ukraine · 3 relevant products
Reddot Biotech Inc.
United States · 1 relevant product
Xema Oy
Finland · 2 relevant products
Diagnostics Biochem Canada Inc.
Canada · 4 relevant products
Pishtaz Teb Zaman Diagnostics PJS
Iran · 1 relevant product
J. Mitra & Co. Pvt. Ltd.
India · 1 relevant product
DIA.PRO Diagnostic BioProbes Srl
Italy · 1 relevant product
Haimen Shengbang Laboratory Equipment Co., Ltd
China · 1 relevant product
SJK Global LLC
United States · 1 relevant product
67 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →5 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 107 closest product alternatives
Beijing Hotgen Biotech Co.,Ltd · China
ELISA-based diagnostic kit for tumor marker detection and quantification. Supports cancer screening and monitoring in laboratory settings.
Vitrotest Bioreagent LLC · Ukraine
ELISA test kit for the quantitative determination of tumor markers in human serum or plasma. Supports oncology laboratory diagnostics and cancer screening.
Reddot Biotech Inc. · United States
ELISA kit designed for the detection and quantification of tumor necrosis factor in biological samples. Delivers precise measurement capabilities for inflammatory response research.
Xema Oy · Finland
ELISA test kits for in vitro diagnostics of human diseases, including determination of tumor markers, hormones, infection markers, and humoral immunity parameters. These tests are designed for clinical diagnostic applications in human medicine.
Diagnostics Biochem Canada Inc. · Canada
An enzyme-linked immunosorbent assay (ELISA) kit for the quantitative measurement of total prostate specific antigen in human serum samples. The assay has an assay time of 105 minutes, a shelf stability of 12 months, and a sensitivity of 0.1 ng/mL. Reference: CAN-TPSA-4300.
Pishtaz Teb Zaman Diagnostics PJS · Iran
ELISA diagnostic test products for laboratory use in medical diagnostics and analysis.
J. Mitra & Co. Pvt. Ltd. · India
Enzyme immunoassay for procalcitonin measurement. Aids in bacterial infection diagnosis and sepsis assessment.
Diagnostics Biochem Canada Inc. · Canada
An enzyme-linked immunosorbent assay (ELISA) kit for the quantitative measurement of thyroid stimulating hormone in human serum samples. The assay has an assay time of 105 minutes, a shelf stability of 18 months, and a sensitivity of 0.1 μIU/mL. Reference: CAN-TSH-4080.
Vitrotest Bioreagent LLC · Ukraine
In vitro diagnostic ELISA kit for the qualitative and semiquantitative determination of antibodies to Treponema pallidum in human serum or plasma samples.
Diagnostics Biochem Canada Inc. · Canada
An enzyme-linked immunosorbent assay kit for quantitative measurement of anti-thyroglobulin antibodies. The assay has a sensitivity of 2.061 IU/mL, requires 80 minutes for completion, and maintains stability for 12 months.
DIA.PRO Diagnostic BioProbes Srl · Italy
An ELISA-based diagnostic test for tropical diseases. This assay is designed for serological detection of pathogens associated with tropical and emerging infectious diseases.
Xema Oy · Finland
Enzyme-linked immunosorbent assay tests designed for clinical diagnostic applications. These tests utilize antibodies and antigens for detection and quantification of specific biomarkers in patient samples.
95 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products